Profil
Paul Dick is currently a Partner at Vet Venture Capital, Inc. He was previously the Chief Executive Officer & Director at Avivagen, Inc. from 2008 to 2010.
He also served as a Director at AbCelex Technologies, Inc. Dr. Dick holds a doctorate degree from the University of Guelph.
Postes actifs de Paul Dick
| Sociétés | Poste | Début |
|---|---|---|
Vet Venture Capital, Inc.
Vet Venture Capital, Inc. Investment ManagersFinance Vet Venture Capital invests in companies operating in the fields of food & companion animal health markets that develop pharmaceuticals, vaccines, diagnostics, science-based wellness products and drug delivery mechanisms. The firm initially invests in the range of $100K to $5 million and also participates in the follow-on rounds of investments. It acts as a lead investor, along with con-investments and takes both minority & majority interests, also seeks board seat requirement. | Private Equity Investor | - |
Anciens postes connus de Paul Dick
| Sociétés | Poste | Fin |
|---|---|---|
| AVIVAGEN INC. | President | 01/10/2010 |
AbCelex Technologies, Inc.
AbCelex Technologies, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur/Membre du Conseil | - |
Formation de Paul Dick
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Guelph
University of Guelph Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avivagen, Inc.
Avivagen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes health supplements for animals & pets | Commercial Services |
Vet Venture Capital, Inc.
Vet Venture Capital, Inc. Investment ManagersFinance Vet Venture Capital invests in companies operating in the fields of food & companion animal health markets that develop pharmaceuticals, vaccines, diagnostics, science-based wellness products and drug delivery mechanisms. The firm initially invests in the range of $100K to $5 million and also participates in the follow-on rounds of investments. It acts as a lead investor, along with con-investments and takes both minority & majority interests, also seeks board seat requirement. | Finance |
AbCelex Technologies, Inc.
AbCelex Technologies, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
















